Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benoit J Arsenault

Showing results (111-120 of 159) with videos related to

Pageof 16
Sort By:
Plos One|December 23, 2014
Prediction of cardiovascular events in statin-treated stable coronary patients of the treating to new targets randomized controlled trial by lipid and non-lipid biomarkersBenoit J Arsenault, Philip Barter, David A DeMicco, et al.
JACC. Basic to Translational Science|October 5, 2020
Interaction of Autotaxin With Lipoprotein(a) in Patients With Calcific Aortic Valve StenosisRaphaëlle Bourgeois, Romain Devillers, Nicolas Perrot, et al.
Journal of the American College of Cardiology|December 28, 2010
Prediction of cardiovascular events in statin-treated stable coronary patients by lipid and nonlipid biomarkersBenoit J Arsenault, Philip Barter, David A DeMicco, et al.
Journal of Clinical Lipidology|November 7, 2017
Effect of atorvastatin, cholesterol ester transfer protein inhibition, and diabetes mellitus on circulating proprotein subtilisin kexin type 9 and lipoprotein(a) levels in patients at high cardiovascular riskBenoit J Arsenault, Francine Petrides, Fatiha Tabet, et al.
Circulation. Genomic and Precision Medicine|July 19, 2021
Sex-Specific Associations of Genetically Predicted Circulating Lp(a) (Lipoprotein(a)) and Hepatic <i>LPA</i> Gene Expression Levels With Cardiovascular Outcomes: Mendelian Randomization and Observational AnalysesJakie Guertin, Yannick Kaiser, Hasanga Manikpurage, et al.
JACC. Cardiovascular Interventions|November 10, 2018
Multimarker Approach to Identify Patients With Higher Mortality and Rehospitalization Rate After Surgical Aortic Valve Replacement for Aortic StenosisBrian R Lindman, Marie-Annick Clavel, Rami Abu-Alhayja'a, et al.
Journal of the American College of Cardiology|September 12, 2015
Oxidized Phospholipids, Lipoprotein(a), and Progression of Calcific Aortic Valve StenosisRomain Capoulade, Kwan L Chan, Calvin Yeang, et al.
The Journal of Clinical Endocrinology and Metabolism|September 23, 2017
Acute and Chronic Impact of Bariatric Surgery on Plasma LDL Cholesterol and PCSK9 Levels in Patients With Severe ObesityMarjorie Boyer, Marie-Eve Piché, Audrey Auclair, et al.
JACC. Advances|June 28, 2024
Multimarker Approach to Improve Risk Stratification of Patients Undergoing Transcatheter Aortic Valve ImplantationSébastien Hecht, Carlos Giuliani, Jorge Nuche, et al.
Communications Medicine|October 17, 2022
Mendelian randomization prioritizes abdominal adiposity as an independent causal factor for liver fat accumulation and cardiometabolic diseasesEloi Gagnon, William Pelletier, Émilie Gobeil, et al.
Pageof 16

Showing results (111-120 of 159) with videos related to

Sort By:
Pageof 16
Plos One|December 23, 2014
Prediction of cardiovascular events in statin-treated stable coronary patients of the treating to new targets randomized controlled trial by lipid and non-lipid biomarkersBenoit J Arsenault, Philip Barter, David A DeMicco, et al.
JACC. Basic to Translational Science|October 5, 2020
Interaction of Autotaxin With Lipoprotein(a) in Patients With Calcific Aortic Valve StenosisRaphaëlle Bourgeois, Romain Devillers, Nicolas Perrot, et al.
Journal of the American College of Cardiology|December 28, 2010
Prediction of cardiovascular events in statin-treated stable coronary patients by lipid and nonlipid biomarkersBenoit J Arsenault, Philip Barter, David A DeMicco, et al.
Journal of Clinical Lipidology|November 7, 2017
Effect of atorvastatin, cholesterol ester transfer protein inhibition, and diabetes mellitus on circulating proprotein subtilisin kexin type 9 and lipoprotein(a) levels in patients at high cardiovascular riskBenoit J Arsenault, Francine Petrides, Fatiha Tabet, et al.
Circulation. Genomic and Precision Medicine|July 19, 2021
Sex-Specific Associations of Genetically Predicted Circulating Lp(a) (Lipoprotein(a)) and Hepatic <i>LPA</i> Gene Expression Levels With Cardiovascular Outcomes: Mendelian Randomization and Observational AnalysesJakie Guertin, Yannick Kaiser, Hasanga Manikpurage, et al.
JACC. Cardiovascular Interventions|November 10, 2018
Multimarker Approach to Identify Patients With Higher Mortality and Rehospitalization Rate After Surgical Aortic Valve Replacement for Aortic StenosisBrian R Lindman, Marie-Annick Clavel, Rami Abu-Alhayja'a, et al.
Journal of the American College of Cardiology|September 12, 2015
Oxidized Phospholipids, Lipoprotein(a), and Progression of Calcific Aortic Valve StenosisRomain Capoulade, Kwan L Chan, Calvin Yeang, et al.
The Journal of Clinical Endocrinology and Metabolism|September 23, 2017
Acute and Chronic Impact of Bariatric Surgery on Plasma LDL Cholesterol and PCSK9 Levels in Patients With Severe ObesityMarjorie Boyer, Marie-Eve Piché, Audrey Auclair, et al.
JACC. Advances|June 28, 2024
Multimarker Approach to Improve Risk Stratification of Patients Undergoing Transcatheter Aortic Valve ImplantationSébastien Hecht, Carlos Giuliani, Jorge Nuche, et al.
Communications Medicine|October 17, 2022
Mendelian randomization prioritizes abdominal adiposity as an independent causal factor for liver fat accumulation and cardiometabolic diseasesEloi Gagnon, William Pelletier, Émilie Gobeil, et al.
Pageof 16